OvaScience Board Ducks Shareholders' IVF Treatment Suit
The board of OvaScience Inc. on Friday escaped a derivative suit brought by shareholders who claim that misleading statements about an in vitro fertilization treatment caused a sharp stock drop, after a...To view the full article, register now.
Already a subscriber? Click here to view full article